GSK waves goodbye to West London as breakup begins with new £120m HQ October 11, 2021 GlaxoSmithKline will move its global headquarters to a new £120m site, as the pharmaceutical giant prepares to split up its empire into two separate businesses. The company today announced plans for a shiny new £120m headquarters in Weybridge for its new independent consumer healthcare company. Remaining pharmaceuticals and vaccine staff will also relocate from the [...]
Covid protection from Pfizer vaccine drops to 47 per cent six months after second dose October 5, 2021 The effectiveness of the Pfizer/BioNTech SE vaccine in preventing infection by the coronavirus dropped to 47 per cent from 88 per cent six months after the second dose, according to data published that U.S. health agencies considered when deciding on the need for booster shots. Watch the full report.
New Covid vaccine formulation could be needed by mid-2022, says BioNTech boss October 4, 2021 The boss of BioNTech, the German biotech firm behind the Pfizer Covid-19, has predicted that a new formulation for jabs will likely be needed by mid-2022. Scientists have warned that the virus could mutate in a way that means it is less resistant to vaccines. “This year [a different vaccine] is completely unneeded. But by [...]
Your third Covid shot is coming: All you need to know about booster vaccines October 3, 2021 It seems inevitable: a third Covid shot is coming your way this Autumn. Two jabs may not give us sufficient protection, or at least not in the long term. Booster jabs are being offered as part of a ramped-up vaccine campaign in England. Some 1.5 million people will be contacted and encouraged to use the [...]
New Covid-19 pill in Germany exceeds all expectations as it reduces Coronavirus deaths by half October 3, 2021 A new experimental Covid-19 pill reduced stays in hospital and deaths by half, according to German multinational science and technology company Merck. In fact, an independent group of medical experts that monitored the trial recommended stopping it early because the interim results were so strong, beating all expectations. The company said today it would soon [...]
Pfizer and Moderna down: Merck’s stock skyrockets after its new Covid antiviral pill smashes all expectations October 1, 2021 Shares in US science giant Merck are up by more than 10 per cent this afternoon after the company revealed a newly developed Covid-19 pill smashes all expectations. As a result, vaccine giants across the board are down, Pfizer by nearly 2 per cent, Moderna 4.7 per cent and Novavax dropped by 7.5%. The companies [...]
‘Your move, Mark’: After YouTube ban Facebook becomes primary anti-vaxx platform in the world October 1, 2021 As YouTube cracks down on anti-vax content, an activisit group has warned Facebook is now the main platform for spreading and sharing anti-Covid vaccine messages. The Center for Countering Digital Hate, which exposes accounts of individuals that share and spread anti-vaccine content circulating on social media, has called on Facebook to follow YouTube’s latest crackdown. The [...]
Jabs for young people set to give Britain even more protection October 1, 2021 | Sponsored The UK’s vaccine rollout has been a success story, allowing us to return to our normal lives. Across the country people have been enjoying catching up with friends and family and doing the things they love. The next step in the Government’s strategy for keeping us safe from Covid-19 is the roll-out of the vaccine [...]
Oxford Nanopore soars on London debut, touching £5bn September 30, 2021 Shares in genome sequencing company Oxford Nanopore rocketed as much as 45 per cent this morning after its IPO, in the best-ever London market debut for a company of its size. Oxford Nanopore shares were trading at 619p per share at market open, pushing its market cap up to £4.93bn – significantly higher than the [...]
Vaccine competition: Sanofi shelves mRNA-based Covid jab work September 28, 2021 French pharmaceutical giant Sanofi has shelved plans for its own mRNA-based Covid-19 jab due to the vaccine-success and dominance of rivals Pfizer and Moderna. Instead, Sanofi is set to focus on a different coronavirus vaccine making approach with its British partner GlaxoSmithKline (GSK). It signals the growing weight of the companies, namely BioNTech-Pfizer, Moderna and [...]